The Health Secretary told the coronavirus daily press briefing that AstraZeneca has struck a deal for the manufacture of the Oxford vaccine. Mr Hancock added that the Imperial vaccine is now in the first phase of human trails.
Mr Hancock said: "In the long run, the best way to defeat this virus is through the discovery of a vaccine.
"Since the start, we have been supporting the most promising projects.
"As of this week, the Imperial vaccine is now in the first phase of human clinical trials.
"AstraZeneca has struck a deal for the manufacture of the Oxford vaccine.
READ MORE: UK population could receive COVID-19 vaccination in time for CHRISTMAS
"They are starting manufacturing now even ahead of approval so we can build up a stockpile and be ready should it be clinically approved.
"We are starting the manufacture of the Oxford vaccine now."
Earlier in June, a Regius Professor of Medicine at Oxford University stated that the COVID-19 vaccine could be approved by the middle of September.
Sir John Bell told Channel 4 News that the phase 3 programme to evaluate the coronavirus vaccine is fully underway.
"Certainly 60 million doses by Christmas."The Oxford Professor continued: "Fingers crossed tailed wind behind us we could have a vaccine approved by the middle of September.
"If we do then it would mean we could get the population vaccinated by Christmas."
At the time of writing, Britain has the fifth-highest number of COVID-19 cases in the world.
The UK has more than 300,000 cases in total and the current official death toll stands at over 42,000.
https://news.google.com/__i/rss/rd/articles/CBMieWh0dHBzOi8vd3d3LmV4cHJlc3MuY28udWsvbmV3cy91ay8xMjk3ODY3L0Nvcm9uYXZpcnVzLXZhY2NpbmUtbGF0ZXN0LXVrLWltcGVyaWFsLWRydWctaHVtYW4tdHJpYWwtYXN0cmF6ZW5lY2EtbWFudWZhY3R1cmXSAX1odHRwczovL3d3dy5leHByZXNzLmNvLnVrL25ld3MvdWsvMTI5Nzg2Ny9Db3JvbmF2aXJ1cy12YWNjaW5lLWxhdGVzdC11ay1pbXBlcmlhbC1kcnVnLWh1bWFuLXRyaWFsLWFzdHJhemVuZWNhLW1hbnVmYWN0dXJlL2FtcA?oc=5
2020-06-18 16:53:44Z
52780861822464
Tidak ada komentar:
Posting Komentar